Investors Should Take Note Of Esperion Therapeutics Inc. (ESPR)
Esperion Therapeutics Inc. (ESPR) concluded trading on Wednesday at a closing price of $1.74, with 3.1 million shares of worth about $5.4 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -15.12% during that period and on September 11, 2024 the price saw a […]
Is There More Upside Ahead For Esperion Therapeutics Inc. (NASDAQ: ESPR)
Esperion Therapeutics Inc. (ESPR) concluded trading on Wednesday at a closing price of $1.82, with 3.47 million shares of worth about $6.32 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -24.17% during that period and on September 04, 2024 the price saw a […]
Is Esperion Therapeutics Inc. (NASDAQ: ESPR) Proving The Doubters Wrong?
Esperion Therapeutics Inc. (ESPR) concluded trading on Wednesday at a closing price of $1.70, with 3.23 million shares of worth about $5.5 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -33.85% during that period and on August 28, 2024 the price saw a […]
Esperion Therapeutics Inc. (NASDAQ: ESPR) – Suitable For Long Term Buy?
Currently, there are 189.46M common shares owned by the public and among those 171.98M shares have been available to trade. The company’s stock has a 5-day price change of -12.80% and -15.98% over the past three months. ESPR shares are trading -38.46% year to date (YTD), with the 12-month market performance up to 9.52% higher. […]
An Important Check-Up On Esperion Therapeutics Inc. (NASDAQ: ESPR)
Esperion Therapeutics Inc. (ESPR) concluded trading on Thursday at a closing price of $2.18, with 3.42 million shares of worth about $7.45 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 1.87% during that period and on August 01, 2024 the price saw a […]
Esperion Therapeutics Inc. (NASDAQ: ESPR): Analyst View Points To Future Growth
Esperion Therapeutics Inc. (ESPR) concluded trading on Tuesday at a closing price of $2.72, with 4.48 million shares of worth about $12.18 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 49.45% during that period and on June 18, 2024 the price saw a […]
Institutional Exposure To Esperion Therapeutics Inc. (ESPR)
Esperion Therapeutics Inc. (ESPR) concluded trading on Wednesday at a closing price of $2.61, with 4.62 million shares of worth about $12.07 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 76.35% during that period and on Wednesday the price saw a loss of […]
Esperion Therapeutics Inc. (NASDAQ: ESPR) Stock In Prove Me State
Esperion Therapeutics Inc. (ESPR) concluded trading on Thursday at a closing price of $2.66, with 2.99 million shares of worth about $7.95 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 73.86% during that period and on Thursday the price saw a gain of […]
Do Esperion Therapeutics Inc. (NASDAQ: ESPR) Fit In A Value Investing Philosophy?
Currently, there are 170.42M common shares owned by the public and among those 169.06M shares have been available to trade. Insiders at the company have transacted a total of 31 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 17 of these insider trades were purchases, […]
Growth Story Still Intact For Esperion Therapeutics Inc. (ESPR)
Esperion Therapeutics Inc. (ESPR) concluded trading on Wednesday at a closing price of $2.14, with 6.62 million shares of worth about $14.18 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 26.63% during that period and on Wednesday, January 31 the price saw a […]
